425: Strive, Semler Scientific Advance Merger Plans

Strive, Inc. and Semler Scientific, Inc. provide an update on their proposed business combination, emphasizing cautionary statements regarding forward-looking information.

Summary

• Strive, Inc. and Semler Scientific, Inc. are proceeding with a proposed business combination.
• The communication was reposted by Matthew Cole, Chief Executive Officer of Strive, on September 25, 2025.
• The filing includes extensive cautionary statements regarding forward-looking information related to the merger.
• Strive intends to file a Registration Statement on Form S-4, which will encompass an Information Statement/Proxy Statement/Prospectus.
• Semler Scientific stockholders will be required to approve the proposed transaction.
• Investors are strongly advised to review the Registration Statement and Information Statement/Proxy Statement/Prospectus once they become available.

Sentiment

Score: 5

Explanation: The filing is a procedural update on a proposed merger, heavily focused on standard cautionary forward-looking statements and a comprehensive list of risks. It does not present new operational results or specific financial performance, maintaining a neutral stance with a necessary emphasis on potential challenges inherent in such transactions.

Positives

• The proposed transaction is expected to yield strategic and financial benefits for the combined company.
• Anticipated cost savings and strategic gains are projected from the business combination.

Risks

• The merger agreement could be terminated due to unforeseen events, changes, or circumstances.
• The proposed transaction may not close as expected or at all if closing conditions are not met timely.
• Potential legal proceedings could be instituted against Strive, Semler Scientific, or the combined entity.
• Anticipated benefits, including cost savings and strategic gains, may not be realized, partly due to risks associated with Bitcoin treasury strategies and digital assets.
• Integration of the two companies could be more difficult, time-consuming, or costly than projected.
• The proposed transaction may incur higher expenses or take longer to complete than anticipated.
• Management's attention may be diverted from ongoing business operations and opportunities.
• Strive's issuance of additional Class A common stock in connection with the merger will cause dilution.
• Potential adverse reactions from customers or changes to business or employee relationships may arise from the announcement or completion of the transaction.
• Changes in Strive's or Semler Scientific's share price could occur before closing.
• General economic and market conditions, interest and exchange rates, monetary policy, and regulatory changes could impact the combined company.
• Other unknown or unpredictable factors could harm the results of Strive, Semler Scientific, or the combined company.

Future Outlook

The companies anticipate strategic and financial benefits from the proposed business combination, including expected cost savings and a positive impact on the combined company's future financial performance. However, these forward-looking statements are subject to inherent risks and uncertainties that could cause actual results to differ materially.

Management Comments

• Matthew Cole, Chief Executive Officer of Strive, reposted the communication on X.com on September 25, 2025, in connection with the proposed business combination.

Industry Context

This filing is a procedural update on a specific corporate transaction and does not provide broader industry context or trends.

Legal Proceedings

• The filing identifies the outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company as a potential risk, but does not detail any current proceedings.

Related Party Transactions

• The filing refers to Semler Scientific's definitive proxy statement for its 2025 Annual Meeting of Stockholders for information on 'transactions with related persons,' but does not detail any specific related party dealings within this document.

Stakeholder Impact

• Potential adverse reactions from customers and changes to business or employee relationships are identified as risks stemming from the proposed transaction.
• Strive shareholders face potential dilution due to the issuance of additional Class A common stock in connection with the merger.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register Class A common stock to be issued in the transaction.
• The Registration Statement will include an Information Statement/Proxy Statement/Prospectus.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders.
• Semler Scientific stockholders will vote to approve the proposed transaction.

Key Dates

Keywords

Strive, Semler Scientific, merger, business combination, SEC filing, Form 425, forward-looking statements, corporate governance, risk management, Bitcoin, digital assets